While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.
Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?
It’s never been easier to take methadone, the daily dose of opioid-blocking medicine that is vital for many in addiction ...
Similar industry-backed bills have passed in 14 states, including Oregon, Texas, Kentucky, and Maryland, according to the ...
Sitting across from patients as a University of Iowa nurse practitioner — now certified in addiction medicine — Aschoff turns ...
President Trump suspended tariffs intended to stop fentanyl from entering the United States. Here’s what to know about the ...
MedPage Today on MSN6dOpinion
A Tale of Two Mental Health Crises
Perhaps just as important, mental health advocates have greatly reduced the stigma associated with depression through major ...
Intermountain Health has a new program to help pregnant moms who are struggling with substance use feel safe, ask for help, ...
Thanks to the implementation of effective policy, the number of drug overdose deaths in the United States fell by nearly 24% in 2024. Members of Congress must act to preserve these policies and gains.
A study of people who started ADHD stimulant treatment via telehealth vs in-person visits shows no difference in risk of new substance use disorders except for young adults age 26-34.